Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Accumulated Expenses: 2021-2024

Historic Other Accumulated Expenses for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $46.9 million.

  • LifeStance Health's Other Accumulated Expenses fell 264.95% to $42.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year decrease of 264.95%. This contributed to the annual value of $46.9 million for FY2024, which is 3407.4% up from last year.
  • LifeStance Health's Other Accumulated Expenses amounted to $46.9 million in FY2024, which was up 3407.4% from $35.0 million recorded in FY2023.
  • LifeStance Health's Other Accumulated Expenses' 5-year high stood at $46.9 million during FY2024, with a 5-year trough of $26.5 million in FY2021.
  • Over the past 4 years, LifeStance Health's median Other Accumulated Expenses value was $32.7 million (recorded in 2022), while the average stood at $34.7 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 1477.93% in 2022, then surged by 3407.4% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Other Accumulated Expenses stood at $26.5 million in 2021, then grew by 14.78% to $30.4 million in 2022, then rose by 15.07% to $35.0 million in 2023, then skyrocketed by 34.07% to $46.9 million in 2024.
  • Its Other Accumulated Expenses stands at $46.9 million for FY2024, versus $35.0 million for FY2023 and $30.4 million for FY2022.